Concepedia

Christopher Biorn

CB

4

Publications

114

Citations

4

H-Index

2012

Active since

Affiliations

Amgen (United States)(Current)

Christopher Biorn is an author at Amgen (United States) specializing in drug discovery, neuropharmacology, and natural sciences.

Top concepts

Publications per year

2012–2014

4

Publications

4

Design, Optimization, and Biological Evaluation of Novel Keto-Benzimidazoles as Potent and Selective Inhibitors of Phosphodiesterase 10A (PDE10A)

Essa Hu, Roxanne K. Kunz, Ning Chen et al. · Journal of Medicinal Chemistry · 2013 · 43 citations · Full text

, , +17

Rapid Identification of a Novel Small Molecule Phosphodiesterase 10A (PDE10A) Tracer

Essa Hu, Ji Ma, Christopher Biorn et al. · Journal of Medicinal Chemistry · 2012 · 28 citations · Full text

, , +19

Discovery of Novel Imidazo[4,5-<i>b</i>]pyridines as Potent and Selective Inhibitors of Phosphodiesterase 10A (PDE10A)

Essa Hu, Kristin L. Andrews, Samer Chmait et al. · ACS Medicinal Chemistry Letters · 2014 · 25 citations · Full text

AMG 580: A Novel Small Molecule Phosphodiesterase 10A (PDE10A) Positron Emission Tomography Tracer

Hang Chen, Dianna Lester-Zeiner, Jianxia Shi et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 18 citations

Rows per page

1–4 of 4